Federal Appeals Court Reaffirms Biosimilar Launch Rules
July 6, 2016
Ned Pagliarulo
BioPharma Dive
Axinn counsel Stacie Ropka was quoted in the BioPharma Dive article, "Federal Appeals Court Reaffirms Biosimilar Launch Rules."
Click here to access the article.